Telesta Therapeutics Inc  

(Public, TSE:TST)   Watch this stock  
Find more results for TSE:BNC
0.230
+0.005 (2.22%)
Delayed:   11:06AM EST
TSE data delayed by 15 mins - Disclaimer
Currency in CAD
Range 0.20 - 0.23
52 week 0.20 - 0.27
Open 0.22
Vol / Avg. 51,964.00/211,423.00
Mkt cap 38.58M
P/E     -
Div/yield     -
EPS -0.27
Shares 167.74M
Beta 0.83
Inst. own     -
Nov 12, 2014
Q1 2015 Bioniche Life Sciences Inc Earnings Release
  

Key stats and ratios

Q3 (Sep '14) 2014
Net profit margin -1274.35% -22818.92%
Operating margin -1245.22% -21108.11%
EBITD margin - -9347.57%
Return on average assets -35.14% -88.91%
Return on average equity -253.86% -
Employees 53 -
CDP Score - -

Address

231 Dundas Street East, Stn Csc PO Box 1570
BELLEVILLE, ON K8N 5J2
Canada
+1-613-9668058 (Phone)
+1-613-9664177 (Fax)

Website links

Description

Telesta Therapeutics Inc., formerly Bioniche Life Sciences Inc., is a late stage human therapeutics company. The Company is focused on the manufacturing, marketing and licensing/acquisition of therapies for the global human health market.

Officers and directors

James M. Rae Independent Chairman of the Board
Michael Joseph Berendt Ph.D. Chief Executive Officer, Chief Scientific Officer
Age: 65
Brian R. Ford Chief Financial Officer
Age: 65
Donald Olds Chief Operating Officer
Mohamed Elrafih Vice President - Manufacturing Operations
Yvon Bastien Independent Director
Age: 66
Roderick Edward Budd Independent Director
Age: 62
Lyne Fortin Independent Director
Gregory David Gubitz Independent Director